DOCSLIB.ORG

PSMD9 Monoclonal Antibody Catalog Number:67338-1-Ig Featured Product

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PSMD9 Monoclonal Antibody Catalog Number:67338-1-Ig Featured Product For Research Use Only PSMD9 Monoclonal antibody Catalog Number:67338-1-Ig Featured Product www.ptglab.com Catalog Number: GenBank Accession Number: Purification Method: Basic Information 67338-1-Ig BC004213 Protein A purification Size: GeneID (NCBI): CloneNo.: 150UL , Concentration: 940 μg/ml by 5715 1H2G1 Bradford method using BSA as the Full Name: Recommended Dilutions: standard; proteasome (prosome, macropain) WB 1:1000-1:5600 Source: 26S subunit, non-ATPase, 9 IHC 1:400-1:1600 Mouse Calculated MW: IF 1:200-1:800 Isotype: 27 kDa IgG1 Observed MW: Immunogen Catalog Number: 30 kDa AG25654 Applications Tested Applications: Positive Controls: IF, IHC, WB,ELISA WB : HEK-293 cells, A549 cells, 4T1 cells, NIH/3T3 Species Specificity: cells, HSC-T6 cells, Jurkat cells, HepG2 cells, K-562 Human, mouse, rat cells, LNCap cells, HeLa cells Note-IHC: suggested antigen retrieval with IHC : human cervical cancer tissue, TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate IF : HeLa cells, buffer pH 6.0 PSMD9 is a ubiquitous protein of eukaryotic cells and is a chaperon of the 26S proteasome complex, which degrades Background Information ubiquitinated proteins in eukaryotic cells and contributes to the degradation of intracellular proteins into antigenic peptides for antigen presentation by MHC class I cells. The 26S mammalian base sub-complex involves three distinct modules which have ATPase subunits distinctly associated to three chaperones, one of which is PSMD9 regulating the modules assembly. The PSMD9 ubiquitous regulatory role within the proteasome implies its potential pleiotropic effects within different physio-pathological systems. PSMD9 is known to form a stable subcomplex with PSMC3 and PSMC6, two of the AAA-ATPases, assisting in the assembly of the 20S and 19S particles to form the holo complex. Storage: Storage Store at -20°C. Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.3. Aliquoting is unnecessary for -20ºC storage For technical support and original validation data for this product please contact: This product is exclusively available under Proteintech T: 1 (888) 4PTGLAB (1-888-478-4522) (toll free E: [email protected] Group brand and is not available to purchase from any in USA), or 1(312) 455-8498 (outside USA) W: ptglab.com other manufacturer. Selected Validation Data Various lysates were subjected to SDS PAGE WB result of PSMD9 antibody (67338-1-Ig; 1:1000; Immunohistochemical analysis of paraffin- followed by western blot with 67338-1-Ig (PSMD9 incubated at room temperature for 1.5 hours) with embedded human cervical cancer tissue slide using antibody) at dilution of 1:2800 incubated at room sh-Control and sh-PSMD9 transfected A549 cells. 67338-1-Ig (PSMD9 antibody) at dilution of 1:800 temperature for 1.5 hours. (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). Immunohistochemical analysis of paraffin- Immunofluorescent analysis of (-20°C Ethanol) embedded human cervical cancer tissue slide using fixed HeLa cells using PSMD9 antibody (67338-1-Ig, 67338-1-Ig (PSMD9 antibody) at dilution of 1:800 Clone: 1H2G1 ) at dilution of 1:400 and (under 10x lens). Heat mediated antigen retrieval CoraLite®488-Conjugated AffiniPure Goat Anti- with Tris-EDTA buffer (pH 9.0). Mouse IgG(H+L)..
Load more

Recommended publications
  • Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Co-Regulator in Invasive 6 Lobular Carcinoma of the Breast 7 8 Evelyn K
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.16.423142; this version posted December 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Running Title: MDC1 co-regulates ER in ILC 2 3 Research article 4 5 Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive 6 lobular carcinoma of the breast 7 8 Evelyn K. Bordeaux1+, Joseph L. Sottnik1+, Sanjana Mehrotra1, Sarah E. Ferrara2, Andrew E. Goodspeed2,3, James 9 C. Costello2,3, Matthew J. Sikora1 10 11 +EKB and JLS contributed equally to this project. 12 13 Affiliations 14 1Dept. of Pathology, University of Colorado Anschutz Medical Campus 15 2Biostatistics and Bioinformatics Shared Resource, University of Colorado Comprehensive Cancer Center 16 3Dept. of Pharmacology, University of Colorado Anschutz Medical Campus 17 18 Corresponding author 19 Matthew J. Sikora, PhD.; Mail Stop 8104, Research Complex 1 South, Room 5117, 12801 E. 17th Ave.; Aurora, 20 CO 80045. Tel: (303)724-4301; Fax: (303)724-3712; email: [email protected]. Twitter: 21 @mjsikora 22 23 Authors' contributions 24 MJS conceived of the project. MJS, EKB, and JLS designed and performed experiments. JLS developed models 25 for the project. EKB, JLS, SM, and AEG contributed to data analysis and interpretation. SEF, AEG, and JCC 26 developed and performed informatics analyses. MJS wrote the draft manuscript; all authors read and revised the 27 manuscript and have read and approved of this version of the manuscript.
    [Show full text]
  • Proteasome System of Protein Degradation and Processing
    ISSN 0006-2979, Biochemistry (Moscow), 2009, Vol. 74, No. 13, pp. 1411-1442. © Pleiades Publishing, Ltd., 2009. Original Russian Text © A. V. Sorokin, E. R. Kim, L. P. Ovchinnikov, 2009, published in Uspekhi Biologicheskoi Khimii, 2009, Vol. 49, pp. 3-76. REVIEW Proteasome System of Protein Degradation and Processing A. V. Sorokin*, E. R. Kim, and L. P. Ovchinnikov Institute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia; E-mail: [email protected]; [email protected] Received February 5, 2009 Abstract—In eukaryotic cells, degradation of most intracellular proteins is realized by proteasomes. The substrates for pro- teolysis are selected by the fact that the gate to the proteolytic chamber of the proteasome is usually closed, and only pro- teins carrying a special “label” can get into it. A polyubiquitin chain plays the role of the “label”: degradation affects pro- teins conjugated with a ubiquitin (Ub) chain that consists at minimum of four molecules. Upon entering the proteasome channel, the polypeptide chain of the protein unfolds and stretches along it, being hydrolyzed to short peptides. Ubiquitin per se does not get into the proteasome, but, after destruction of the “labeled” molecule, it is released and labels another molecule. This process has been named “Ub-dependent protein degradation”. In this review we systematize current data on the Ub–proteasome system, describe in detail proteasome structure, the ubiquitination system, and the classical ATP/Ub- dependent mechanism of protein degradation, as well as try to focus readers’ attention on the existence of alternative mech- anisms of proteasomal degradation and processing of proteins.
    [Show full text]
  • Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
    International Journal of Environmental Research and Public Health Article Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes Yueh-Han Hsu 1,2, Peng-Hui Wang 1,2,3,4,5 and Chia-Ming Chang 1,2,* 1 Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan; [email protected] (Y.-H.H.); [email protected] (P.-H.W.) 2 School of Medicine, National Yang-Ming University, Taipei 112, Taiwan 3 Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan 4 Department of Medical Research, China Medical University Hospital, Taichung 440, Taiwan 5 Female Cancer Foundation, Taipei 104, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2875-7826; Fax: +886-2-5570-2788 Received: 27 April 2020; Accepted: 31 May 2020; Published: 2 June 2020 Abstract: Clear cell carcinoma of the ovary (ovarian clear cell carcinoma (OCCC)) is one epithelial ovarian carcinoma that is known to have a poor prognosis and a tendency for being refractory to treatment due to unclear pathogenesis. Published investigations of OCCC have mainly focused only on individual genes and lack of systematic integrated research to analyze the pathogenesis of OCCC in a genome-wide perspective. Thus, we conducted an integrated analysis using transcriptome datasets from a public domain database to determine genes that may be implicated in the pathogenesis involved in OCCC carcinogenesis. We used the data obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) DataSets. We found six interactive functional gene clusters in the pathogenesis network of OCCC, including ribosomal protein, eukaryotic translation initiation factors, lactate, prostaglandin, proteasome, and insulin-like growth factor.
    [Show full text]
  • Identification of Genomic Targets of Krüppel-Like Factor 9 in Mouse Hippocampal
    Identification of Genomic Targets of Krüppel-like Factor 9 in Mouse Hippocampal Neurons: Evidence for a role in modulating peripheral circadian clocks by Joseph R. Knoedler A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Neuroscience) in the University of Michigan 2016 Doctoral Committee: Professor Robert J. Denver, Chair Professor Daniel Goldman Professor Diane Robins Professor Audrey Seasholtz Associate Professor Bing Ye ©Joseph R. Knoedler All Rights Reserved 2016 To my parents, who never once questioned my decision to become the other kind of doctor, And to Lucy, who has pushed me to be a better person from day one. ii Acknowledgements I have a huge number of people to thank for having made it to this point, so in no particular order: -I would like to thank my adviser, Dr. Robert J. Denver, for his guidance, encouragement, and patience over the last seven years; his mentorship has been indispensable for my growth as a scientist -I would also like to thank my committee members, Drs. Audrey Seasholtz, Dan Goldman, Diane Robins and Bing Ye, for their constructive feedback and their willingness to meet in a frequently cold, windowless room across campus from where they work -I am hugely indebted to Pia Bagamasbad and Yasuhiro Kyono for teaching me almost everything I know about molecular biology and bioinformatics, and to Arasakumar Subramani for his tireless work during the home stretch to my dissertation -I am grateful for the Neuroscience Program leadership and staff, in particular
    [Show full text]
  • Systems Biology Analysis of Osteogenic Differentiation Behavior
    www.nature.com/scientificreports OPEN Systems biology analysis of osteogenic diferentiation behavior by canine mesenchymal stem cells derived from bone marrow and dental pulp Sirirat Nantavisai1,2,3, Trairak Pisitkun4, Thanaphum Osathanon5,6, Prasit Pavasant5,6, Chanin Kalpravidh7, Sirakarnt Dhitavat8, Jiradej Makjaroen4 & Chenphop Sawangmake2,3,9* Utilization of canine mesenchymal stem cells (cMSCs) for regenerating incorrigible bone diseases has been introduced. However, cMSCs harvested from diferent sources showed distinct osteogenicity. To clarify this, comparative proteomics-based systems biology analysis was used to analyze osteogenic diferentiation behavior by cMSCs harvested from bone marrow and dental pulp. The results illustrated that canine dental pulp stem cells (cDPSCs) contained superior osteogenicity comparing with canine bone marrow-derived MSCs (cBM-MSCs) regarding alkaline phosphatase activity, matrix mineralization, and osteogenic marker expression. Global analyses by proteomics platform showed distinct protein clustering and expression pattern upon an in vitro osteogenic induction between them. Database annotation using Reactome and DAVID revealed contrast and unique expression profle of osteogenesis-related proteins, particularly on signaling pathways, cellular components and processes, and cellular metabolisms. Functional assay and hierarchical clustering for tracking protein dynamic change confrmed that cBM-MSCs required the presences of Wnt, transforming growth factor (TGF)-beta, and bone-morphogenetic protein (BMP) signaling, while cDPSCs mainly relied on BMP signaling presentation during osteogenic diferentiation in vitro. Therefore, these fndings illustrated the comprehensive data regarding an in vitro osteogenic diferentiation behavior by cBM-MSCs and cDPSCs which is crucial for further mechanism study and the establishment of cMSC-based bone tissue engineering (BTE) for veterinary practice. Regenerative therapy for reconstructing craniofacial and bone defects is a challenge procedure especially for vet- erinary practice1.
    [Show full text]
  • Supplementary Table 4: the Association of the 26S Proteasome
    Supplementary Material (ESI) for Molecular BioSystems This journal is (c) The Royal Society of Chemistry, 2009 Supplementary Table 4: The association of the 26S proteasome and tumor progression/metastasis Note: the associateion between cancer and the 26S proteasome genes has been manually checked in PubMed a) GSE2514 (Lung cancer, 20 tumor and 19 normal samples; 25 out of 43 26S proteasome genes were mapped on the microarray platform. FWER p-value: 0.02) Entrez GeneID Gene Symbol RANK METRIC SCORE* Genes have been reported in cancer 10213 PSMD14 0.288528293 5710 PSMD4 0.165639699 Kim et al., Mol Cancer Res., 6:426, 2008 5713 PSMD7 0.147187442 5721 PSME2 0.130215749 5717 PSMD11 0.128598183 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 5704 PSMC4 0.123157509 5706 PSMC6 0.115970835 5716 PSMD10 0.112173758 Mayer et al., Biochem Society Transaction, 34:746, 2006 5700 PSMC1 0.0898761 Kim et al., Mol Cancer Res., 6:426, 2008 5701 PSMC2 0.081513479 Cui et al., Proteomics, 6:498, 2005 5709 PSMD3 0.071682706 5719 PSMD13 0.071118504 7415 VCP 0.060464829 9861 PSMD6 0.055711303 Ren et al., Oncogene, 19:1419, 2000 5720 PSME1 0.052469168 5714 PSMD8 0.047414459 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 5702 PSMC3 0.046327863 Pollice et al., JBC, 279:6345, 2003 6184 RPN1 0.043426223 55559 UCHL5IP 0.041885283 5705 PSMC5 0.041615516 5715 PSMD9 0.033147983 5711 PSMD5 0.030562362 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 10197 PSME3 0.015149679 Roessler et al., Molecular & Cellular Proteomics 5:2092, 2006 5718 PSMD12 -0.00983229 Cui et al., Proteomics, 6:498, 2005 9491 PSMF1 -0.069156095 *Positive rank metric score represent that a gene is highly expressed in tumors.
    [Show full text]
  • The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma
    Hindawi BioMed Research International Volume 2021, Article ID 9922185, 9 pages https://doi.org/10.1155/2021/9922185 Research Article The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma Jian-Yu Zhang, Ke-Zhi Shi, Xiang-Yu Liao, Shi-Jun Li, Dan Bao, Ying Qian, and Dao-Jun Li The First College of Clinical Medical Science, Three Gorges University & Yichang Central People’s Hospital, Yichang, China Correspondence should be addressed to Dao-Jun Li; [email protected] Received 8 March 2021; Revised 24 April 2021; Accepted 28 May 2021; Published 19 June 2021 Academic Editor: Tao Huang Copyright © 2021 Jian-Yu Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The proteasome has been validated as an anticancer drug target, while the role of a subunit of proteasome, PSMC6, in lung adenocarcinoma (LUAD) has not been fully unveiled. In this study, we observed that both the RNA and protein of PSMC6 were highly upregulated in LUAD compared with the adjacent normal tissues. Moreover, a high PSMC6 expression was associated with poor prognosis. In accordance with this finding, PSMC6 was associated with poor tumor differentiation. Furthermore, the silence of PSMC6 by small interference RNAs (siRNAs) could significantly inhibit cell growth, migration, and invasion in lung cancer cell lines, suggesting that PSMC6 might serve as a promising therapeutic target in LUAD. To further explore the molecular mechanism of PSMC6 in LUAD, we observed that the proteasome subunits, such as PSMD10, PSMD6, PSMD9, PSMD13, PSMB3, PSMB1, PSMA4, PSMC1, PSMC2, PSMD7, and PSMD14, were highly correlated with PSMC6 expression.
    [Show full text]
  • Integrative Framework for Identification of Key Cell Identity Genes Uncovers
    Integrative framework for identification of key cell PNAS PLUS identity genes uncovers determinants of ES cell identity and homeostasis Senthilkumar Cinghua,1, Sailu Yellaboinaa,b,c,1, Johannes M. Freudenberga,b, Swati Ghosha, Xiaofeng Zhengd, Andrew J. Oldfielda, Brad L. Lackfordd, Dmitri V. Zaykinb, Guang Hud,2, and Raja Jothia,b,2 aSystems Biology Section and dStem Cell Biology Section, Laboratory of Molecular Carcinogenesis, and bBiostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and cCR Rao Advanced Institute of Mathematics, Statistics, and Computer Science, Hyderabad, Andhra Pradesh 500 046, India Edited by Norbert Perrimon, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, and approved March 17, 2014 (received for review October 2, 2013) Identification of genes associated with specific biological pheno- (mESCs) for genes essential for the maintenance of ESC identity types is a fundamental step toward understanding the molecular resulted in only ∼8% overlap (8, 9), although many of the unique basis underlying development and pathogenesis. Although RNAi- hits in each screen were known or later validated to be real. The based high-throughput screens are routinely used for this task, lack of concordance suggest that these screens have not reached false discovery and sensitivity remain a challenge. Here we describe saturation (14) and that additional genes of importance remain a computational framework for systematic integration of published to be discovered. gene expression data to identify genes defining a phenotype of Motivated by the need for an alternative approach for iden- interest. We applied our approach to rank-order all genes based on tification of key cell identity genes, we developed a computa- their likelihood of determining ES cell (ESC) identity.
    [Show full text]
  • Adaptive Mitochondrial Regulation of the Proteasome
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.07.026161; this version posted April 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Adaptive mitochondrial regulation of the proteasome Thomas Meul1, Korbinian Berschneider1, Sabine Schmitt2, 10, Christoph H. Mayr1, Laura F. Mattner1, Herbert B. Schiller1, Ayse Yazgili1, Xinyuan Wang1, Christina Lukas1, Cornelia Prehn3, Jerzy Adamski3, Elisabeth Graf4, Thomas Schwarzmayr4, Fabiana Perocchi5, Alexandra Kukat6, Aleksandra Trifunovic6, Laura Kremer7, Holger Prokisch7, Bastian Popper8; Christine von Toerne9, Stefanie M. Hauck9, Hans Zischka2, 10, Silke Meiners1ê 1 Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Germany. 2 Institute of Toxicology and Environmental Hygiene, Technical University of Munich, Munich, Germany. 3 Institute of Experimental Genetics, Helmholtz Zentrum München, Munich, Germany 4 Institute of Human Genetics, Core Facility Next-Generation-Sequencing, Helmholtz Zentrum München, Munich, Germany 5 Gene Center, Ludwig-Maximilians University, Munich, Germany 6 Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Institute for Mitochondrial Diseases and Aging, University of Cologne, Cologne, Germany 7 Institute of Human Genetics, Genome Analysis Center, Helmholtz Zentrum München,
    [Show full text]
  • PSMD5 Inactivation Promotes 26S Proteasome Assembly During Colorectal Tumor Progression Avi Levin1,2, Adi Minis1, Gadi Lalazar3, Jose Rodriguez1, and Hermann Steller1
    Published OnlineFirst May 1, 2018; DOI: 10.1158/0008-5472.CAN-17-2296 Cancer Molecular Cell Biology Research PSMD5 Inactivation Promotes 26S Proteasome Assembly during Colorectal Tumor Progression Avi Levin1,2, Adi Minis1, Gadi Lalazar3, Jose Rodriguez1, and Hermann Steller1 Abstract Protein degradation by the ubiquitin–proteasome system (UPS) is central to protein homeostasis and cell survival. The active 26S proteasome is a PSMD5 large protease complex consist- Malignant ing of a catalytic 20S subunit transformation and 19S regulatory particles. PSMD5/S5b Cancer cells are exposed to con- down-regulation siderable protein overload due PSMD5 to high metabolic rates, repro- PSMD5 grammed energy metabolism, and aneuploidy. Here we report a mechanism that facilitates the Normal cell Malignant cell assembly of active 26S protea- somes in malignant cells. Upon Downregulation of PSMD5/S5b promotes 26S proteasome assembly, thereby increasing the tumorigenic transformation of proteolytic capacity of colorectal cancer cells, allowing them to maintain protein homeostasis. the gut epithelium, 26S pro- teasome assembly was signifi- © 2018 American Association for Cancer Research cantly enhanced, but levels of individual subunits were not changed. This enhanced assembly of 26S proteasomes increased further with tumor progression and was observed specifically in transformed cells, but not in other rapidly dividing cells. Moreover, expression of PSMD5, an inhibitor of proteasome assembly, was reduced in intestinal tumors and silenced with tumor progression. Reexpression of PSMD5 in tumor cells caused decreased 26S assembly and accumulation of polyubiquitinated proteins. These results suggest that inhibition of cancer-associated proteasome assembly may provide a novel therapeutic strategy to selectively kill cancer cells. Significance: Enhanced cancer-associated proteasome assembly is a major stress response that allows tumors to adapt to and to withstand protein overload.
    [Show full text]
  • Anti-PSMD9 Antibody (ARG41020)
    Product datasheet [email protected] ARG41020 Package: 100 μl anti-PSMD9 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes PSMD9 Tested Reactivity Hu, Rat Tested Application ICC/IF, IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name PSMD9 Antigen Species Human Immunogen Recombinant fusion protein corresponding to aa. 1-223 of Human PSMD9 (NP_002804.2). Conjugation Un-conjugated Alternate Names 26S proteasome non-ATPase regulatory subunit 9; p27; Rpn4; 26S proteasome regulatory subunit p27 Application Instructions Application table Application Dilution ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Jurkat Calculated Mw 25 kDa Observed Size 30 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/3 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol PSMD9 Gene Full Name proteasome 26S subunit, non-ATPase 9 Background The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator.
    [Show full text]
  • Characterization of Gene Expression Patterns in the Wild Pacific Salmon
    Characterization of Gene Expression Patterns in the Wild Pacific Salmon by Evan Morien B.Sc., State University of New York at Buffalo, 2007 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE in The Faculty of Graduate Studies (Bioinformatics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) December 2012 c Evan Morien 2012 Abstract Declines in Pacific salmon stocks in recent decades have spurred much re- search into their physiology and survivorship, but comparatively little into their genomics. Sockeye salmon in particular are experiencing high levels of mortality during their migration upriver, and the numbers of returning sockeye have fluxuated wildly with respect to predictions in recent years. The goal of my project is to gain insight into the basic genomics of Pacific salmon stocks, including the sockeye, through bioinformatic approaches to gene expression profiling. Using microarray technology, I have conducted a large-scale analysis of over 1,000 samples from multiple tissues, stocks, and species of salmon. I identified tissue-specific and housekeeping genes and compared them to orthologs in mouse and human, respectively. I have also classified a number of microarray samples with a support vector machine (SVM) using qPCR data showing the presence of several common pathogens affecting Pacific salmon populations. Using identified housekeeping genes as normalizing factors, I modeled in silico a qPCR assay designed to identify salmon as infected or uninfected with a particular pathogen. With these data I hope to increase basic knowledge of the genomics of the Pacific salmon. ii Preface Contributions The data used in this thesis were generated at the Department of Fish- eries and Oceans Pacific Biological Station in Nanaimo, British Columbia by Kristina M.
    [Show full text]